Clinical trial · Observational
Therapeutic Research in Multiple Myeloma
UARK 91-004 Therapeutic Research in Multiple Myeloma
NCT00572338CI-TRIAL-00018838completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to learn how myeloma cells grow and become a cancer, how to distinguish them from normal cells and how to eliminate these cells selectively.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No drugs are involved | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- patients with myeloma/related diseases
- interventionNames
- Other: No drugs are involved
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Any subject evaluated for a MIRT protocol Exclusion Criteria: * Subjects who have not been evaluated for a MIRT protocol
References
Publications (0)
Data not yet available
No reference posted for this study.